NCT04114981: Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease

NCT04114981
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Phase 3
Drug Category: Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older ¬† (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patient must have 3 or fewer unresected brain metastases that measure less than 4cm and are located more than 5 mm from the optic chiasm & outside the brain stem at the time of screening; Patient must have had one resection of brain metastasis
Exclusions: Patients with more than one resection of brain metastasis; Patients with prior whole brain radiation therapy; Patients with leptomeningeal metastasis (LMD)
https://ClinicalTrials.gov/show/NCT04114981

Comments are closed.

Up ↑